Compositions And Methods For Treating Purpura

Abstract

Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an α adrenergic receptor agonist selected from selective α1 adrenergic receptor agonist, selective α2 adrenergic receptor agonist, non-selective α1/α2 adrenergic receptor agonist, agents with α2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Feb 23, 2016
  • Application: Feb 16, 2014
    US US 201414181706 A
  • Priority: Feb 16, 2014
    US US 201414181706 A
  • Priority: Jan 6, 2012
    US US 201213345472 A
  • Priority: Nov 17, 2008
    US US 27225308 A
  • Priority: Nov 16, 2007
    US US 98856407 P

Sign in to the Lens